About
Longeveron Llc (NASDAQ:LGVN) — investor relations, events, news, and company updates on 6ix.
Latest News
Apr 8 2026
Longeveron Granted Chinese Patent for Potency Assay Methods for Assessing Human Mesenchymal Stem Cells (MSCs)
Mar 17 2026
Longeveron Announces 2025 Full Year Financial Results and Provides Business Update
Mar 12 2026
Longeveron to Report 2025 Full-Year Financial Results and Host Conference Call on March 17, 2026
Mar 11 2026
Longeveron Announces Closing of Private Placement of up to $30 Million
Mar 10 2026
Longeveron Announces Private Placement of up to $30 Million
Financials
Revenue
$1.2 M
Market Cap
$32.21 M
EPS
-1.29
Translate